2015International Journal of Pharmacy and Pharmaceutical SciencesOpen access

ANTIDIABETIC ACTIVITY ON METHANOLIC EXTRACTS OF SCHREBERA SWIETENOIDES ROXB. ROOTS IN STREPTOZOTOCIN INDUCED DIABETIC RATS

Shyam Tulliballi, S. Ganapaty

Open full text 0 citations

Abstract

Objective: The aim of study was to evaluate acute toxicity and antidiabetic activity of methanolic extract of Schrebera swietenoides roots in streptozotocin induced diabetic rats. Methods: Acute toxicity of the methanolic extracts of Schrebera swietenoides roots was studied in Wistar albino rats at a dose level upto 2 g/kg b.w. The animals were also closely examined for signs of intoxication, lethargy, behavioral modification and morbidity. The plant was evaluated for antidiabetic activity against Streptozotocininduced diabetic model in different concentrations of 100,200 and 400 mg/kg body weight. The mean and percent blood glucose reduction levels were calculated and comparable with the standard drug, glibenclamide (0.45 mg/kg b. w). Results: The extracts did not produce any toxic signs during the observation period for 24 h. The oral administration of 400 mg/kg b. w of methanolic extract of Schrebera swietenoides roots showed significant (P<0.05) decrease in blood glucose levels up to 18 th h, more significant (P<0.01) decrease in blood glucose levels at 4 th and 12 th h and highly significant (P<0.001) decrease in blood glucose levels at 8 th h respectively. Conclusions: From the studies it is concluded that, the methanolic extract of Schrebera swietenoides roots is suitable to prepare ayurvedic formulations for the treatment of diabetes.

About this research paper

What this paper is about

Objective: The aim of study was to evaluate acute toxicity and antidiabetic activity of methanolic extract of Schrebera swietenoides roots in streptozotocin induced diabetic rats. Methods: Acute toxicity of the methanolic extracts of Schrebera swietenoides roots was studied in Wistar albino rats at a dose level upto 2 g/kg b.w. The animals were also closely examined for signs of intoxication, lethargy, behavioral modification and morbidity. The plant was evaluated for antidiabetic activity against Streptozotocininduced diabetic model in different concentrations of 100,200 and 400 mg/kg body weight. The mean and percent blood glucose reduction levels were calculated and comparable with the standard drug, glibenclamide (0.45 mg/kg b. w). Results: The extracts did not produce any toxic signs during the observation period for 24 h. The oral administration of 400 mg/kg b. w of methanolic extract of Schrebera swietenoides roots showed significant (P<0.05) decrease in blood glucose levels up to 18 th h, more significant (P<0.01) decrease in blood glucose levels at 4 th and 12 th h and highly significant (P<0.001) decrease in blood glucose levels at 8 th h respectively. Conclusions: From the studies it is concluded that, the methanolic extract of Schrebera swietenoides roots is suitable to prepare ayurvedic formulations for the treatment of diabetes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: The aim of study was to evaluate acute toxicity and antidiabetic activity of methanolic extract of Schrebera swietenoides roots in streptozotocin induced diabetic rats. Methods: Acute toxicity of the methanolic extracts of Schrebera swietenoides roots was studied in Wistar albino rats at a dose level upto 2 g/kg b.w. The animals were also closely examined for signs of intoxication, lethargy, behavioral modification and morbidity. The plant was evaluated for antidiabetic activity against Streptozotocininduced diabetic model in different concentrations of 100,200 and 400 mg/kg body weight. The mean and percent blood glucose reduction levels were calculated and comparable with the standard drug, glibenclamide (0.45 mg/kg b. w). Results: The extracts did not produce any toxic signs during the observation period for 24 h. The oral administration of 400 mg/kg b. w of methanolic extract of Schrebera swietenoides roots showed significant (P<0.05) decrease in blood glucose levels up to 18 th h, more significant (P<0.01) decrease in blood glucose levels at 4 th and 12 th h and highly significant (P<0.001) decrease in blood glucose levels at 8 th h respectively. Conclusions: From the studies it is concluded that, the methanolic extract of Schrebera swietenoides roots is suitable to prepare ayurvedic formulations for the treatment of diabetes.

Key concepts: Glibenclamide, Acute toxicity, Streptozotocin, Diabetes mellitus, Lethargy, Traditional medicine, Toxicity, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
ANTIDIABETIC ACTIVITY ON METHANOLIC EXTRACTS OF SCHREBERA SWIETENOIDES ROXB. ROOTS IN STREPTOZOTOCIN INDUCED DIABETIC RATS — Research Paper | ScholarLens